RN7SL605P

Across TCGA pan-cancer cohorts, RN7SL605P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RN7SL605P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RN7SL605P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL605P expression acts as an unfavorable survival marker, although some lineages such as UCS and LUAD show a favorable association.

UCS, LUAD, and DLBC are the cancer types where RN7SL605P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	III,IV	0.553	0.089	.005	54	view →
LUAD	DFS	Quartile	III,IV	0.916	0.577	.009	21	view →
DLBC	DFS	Tertile	III,IV	0.171	0.833	.029	18	view →
BLCA	OS	Quartile	All	0.798	0.677	.015	14	view →
PAAD	OS	Median	All	0.668	0.544	.035	12	view →
STAD	OS	Tertile	All	0.734	0.619	.015	10	view →
SKCM	OS	Tertile	All	0.852	0.680	.004	9	view →
THCA	OS	Median	All	1.000	0.850	.017	8	view →
SARC	OS	Quartile	All	0.884	0.652	.003	8	view →
KICH	DFS	Median	All	0.737	0.937	.024	5	view →
UCEC	DFS	Median	All	0.800	0.863	.038	4	view →
MESO	DFS	Median	IV	0.453	0.202	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RN7SL605P–UCS (DFS)

Open the UCS breakdown →